av/royalty-pharma--big.svg

COM:ROYALTYPHARMA

Royalty Pharma

  • Stock

USD

Last Close

26.40

22/11 21:00

Market Cap

11.63B

Beta: -

Volume Today

2.46M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
1.34B
-
1.52B
13.00%
2.46B
62.16%
1.70B
30.85%
1.24B
27.07%
230.06M
81.46%
1.13B
393.27%
depreciation and amortization
33.27M
-
33.27M
0%
23.92M
28.08%
23.06M
3.62%
23.00M
0.27%
5.67M
75.34%
deferred income tax
65.49M
-
-1.52B
2,424.57%
stock based compensation
5.43M
-
2.44M
54.99%
2.17M
11.17%
2.36M
8.62%
change in working capital
-1.48B
-
-1.56B
5.88%
-1.67B
7.11%
-1.88B
12.58%
-16.32M
99.13%
32.66M
300.11%
3.21B
9,718.11%
accounts receivables
159.86M
-
-400K
100.25%
-29.14M
7,185.75%
31.71M
208.82%
1.07M
96.64%
inventory
-166.36M
-
400K
100.24%
29.14M
7,185.75%
-31.71M
208.82%
accounts payables
1.35M
-
6.50M
381.19%
-766K
111.79%
-4.59M
498.69%
2.29M
149.85%
6.24M
172.79%
other working capital
-1.48B
-
-1.56B
5.97%
-1.67B
7.02%
-1.88B
12.53%
-11.74M
99.38%
30.38M
358.83%
3.20B
10,432.95%
other non cash items
1.52B
-
1.63B
7.39%
855.40M
47.51%
2.12B
148.15%
2.29B
7.86%
1.87B
18.18%
-1.31B
170.05%
net cash provided by operating activities
1.42B
-
1.62B
14.10%
1.67B
3.02%
2.03B
22.04%
2.02B
0.84%
2.14B
6.27%
3.03B
41.40%
investments in property plant and equipment
269.59M
-
-1.72B
738.48%
2.20B
227.64%
523K
99.98%
2.04B
390,177.63%
-2.12B
203.64%
acquisitions net
-2M
-
-24.17M
1,108.65%
-27.04M
11.87%
-40M
47.92%
-34.85M
12.86%
-9.90M
71.61%
12.45M
225.80%
purchases of investments
-2.30B
-
-422.40M
81.64%
-2.36B
459.57%
-3.94B
66.56%
-3.59B
8.72%
-2.57B
28.62%
-12.54M
99.51%
sales maturities of investments
600M
-
750M
25%
524.55M
30.06%
1.20B
129.34%
1.78B
47.66%
1.55B
12.99%
25.83M
98.33%
other investing activites
115M
-
-269.59M
334.43%
1.47B
645.75%
-2.18B
248.31%
-18.60M
99.15%
-2.04B
10,873.94%
-14.44M
99.29%
net cash used for investing activites
-1.59B
-
303.42M
119.11%
-2.12B
797.42%
-2.76B
30.38%
-1.87B
32.21%
-1.03B
44.96%
-2.10B
104.41%
debt repayment
-193M
-
-294M
52.33%
-294M
0%
-11.21B
3,712.93%
-1.26B
88.76%
-1B
-
common stock issued
4.27M
-
1.91B
44,649.18%
-1.60M
-
common stock repurchased
-4.27M
-
11.89B
278,838.87%
-304.76M
-
dividends paid
-735.17M
-
-814.36M
10.77%
-739.28M
9.22%
-397M
46.30%
-285.18M
28.17%
-333.32M
16.88%
-358.33M
7.50%
other financing activites
804.92M
-
-270.74M
133.64%
-158.35M
41.51%
-706M
345.85%
1.93B
373.34%
-611.53M
131.69%
-496.52M
18.81%
net cash used provided by financing activities
-123.25M
-
-1.38B
1,018.91%
-1.19B
13.59%
1.49B
224.79%
385.11M
74.10%
-944.86M
345.35%
-2.16B
128.73%
effect of forex changes on cash
371K
-
net change in cash
-292.65M
-
542.64M
285.42%
-1.64B
402.32%
763M
146.51%
532.37M
30.23%
169.70M
68.12%
-1.23B
827.00%
cash at beginning of period
1.67B
-
1.38B
17.48%
1.92B
39.28%
246M
87.22%
1.01B
310.03%
1.54B
52.78%
1.71B
11.01%
cash at end of period
1.38B
-
1.92B
39.28%
283.68M
85.26%
1.01B
255.68%
1.54B
52.73%
1.71B
11.01%
477.01M
72.12%
operating cash flow
1.42B
-
1.62B
14.10%
1.67B
3.02%
2.03B
22.04%
2.02B
0.84%
2.14B
6.27%
3.03B
41.40%
capital expenditure
269.59M
-
-1.72B
738.48%
2.20B
227.64%
523K
99.98%
2.04B
390,177.63%
-2.12B
203.64%
free cash flow
1.42B
-
1.89B
33.11%
-54.05M
102.86%
4.23B
7,928.81%
2.02B
52.31%
4.19B
107.38%
916.16M
78.11%

All numbers in USD (except ratios and percentages)